Edwards Lifesciences Corp (EW)
87.42
+2.33
(+2.74%)
USD |
NYSE |
May 09, 16:00
87.41
-0.01
(-0.01%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 52.68B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -1.44% |
Valuation | |
PE Ratio | 37.68 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 8.647 |
Price to Book Value | 7.400 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.0839 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 52.78% |
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US. |
URL | https://www.edwards.com |
Investor Relations URL | https://ir.edwards.com/ |
HQ State/Province | California |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Large Cap/Growth |
Next Earnings Release | Jul. 26, 2024 (est.) |
Last Earnings Release | Apr. 25, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US. |
URL | https://www.edwards.com |
Investor Relations URL | https://ir.edwards.com/ |
HQ State/Province | California |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Large Cap/Growth |
Next Earnings Release | Jul. 26, 2024 (est.) |
Last Earnings Release | Apr. 25, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |